Edition:
United Kingdom

Xenon Pharmaceuticals Inc (XENE.OQ)

XENE.OQ on NASDAQ Stock Exchange Global Market

3.70USD
3:17pm GMT
Change (% chg)

$-0.05 (-1.33%)
Prev Close
$3.75
Open
$3.75
Day's High
$3.75
Day's Low
$3.70
Volume
2,163
Avg. Vol
11,480
52-wk High
$9.90
52-wk Low
$2.15

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Sep '17 0.26 -0.430
Jun '17 0.01 -0.410
Mar '17 0.02 -0.419
FY 2016 Dec '16 0.38 -0.335
Sep '16 0.41 -0.505
Jun '16 0.41 -0.418
Mar '16 0.60 -0.227
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Year Ending Dec-18 3 5.17 13.50 0.00 28.83
Earnings (per share)
Year Ending Dec-18 3 -1.67 -1.07 -2.00 -0.44
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 83.93 32.90
P/E High - Last 5 Yrs. 21.51 292.71 45.97
P/E Low - Last 5 Yrs. 21.51 91.44 24.37
Beta -- 0.90 0.89
Price to Sales (TTM) 65.85 110.72 5.77
Price to Book (MRQ) 1.07 13.56 5.41
Price to Tangible Book (MRQ) 1.07 14.02 6.98
Price to Cash Flow (TTM) -- 71.33 23.42
% Owned Institutions 63.38 12.89 2.22

Dividends

  Company industry sector
Dividend Yield -- 0.31 1.50
Dividend Yield - 5 Year Avg -- 0.26 1.52
Dividend 5 Year Growth Rate -- 1.66 5.21
Payout Ratio(TTM) -- 15.70 43.73

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -96.37 398.34 9.24
Sales (TTM) vs TTM 1 Yr. Ago -90.39 78.63 5.59
Sales - 5 Yr. Growth Rate -23.58 32.11 10.27
EPS (MRQ) vs Qtr. 1 Yr. Ago 1.79 25.10 19.66
EPS (TTM) vs TTM 1 Yr. Ago -40.79 -- --
EPS - 5 Yr. Growth Rate -- 38.95 10.73
Capital Spending - 5 Yr. Growth Rate -0.77 40.24 15.19

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.80 2.18
Current Ratio (MRQ) 13.95 5.30 2.97
LT Debt to Equity (MRQ) 0.00 22.82 12.22
Total Debt to Equity (MRQ) 0.00 24.47 16.52
Interest Coverage (TTM) -9.68 -98.78 33.13

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 40.03 54.70
Gross Margin - 5 Yr. Avg. -- 51.06 52.42
EBITD Margin (TTM) -3,415.37 -- --
EBITD - 5 Yr. Avg -14.16 -572.68 10.86
Operating Margin (TTM) -3,496.71 -717.10 4.64
Operating Margin - 5 Yr. Avg. -18.89 -594.00 6.26
Pre-Tax Margin (TTM) -3,489.63 -691.66 5.44
Pre-Tax Margin - 5 Yr. Avg. -20.59 -597.35 6.60
Net Profit Margin (TTM) -3,489.63 -692.88 1.76
Net Profit Margin - 5 Yr. Avg. -20.59 -600.21 2.91
Effective Tax Rate (TTM) -- 22.57 23.04
Effective Tax Rate - 5 Yr. Avg. -- 18.19 23.96

Efficiency

  Company industry sector
Revenue/Employee (TTM) 9,318 22,602,130 855,673,508
Net Income/Employee (TTM) -325,170 2,968,748 100,656,226
Receivable Turnover (TTM) 1.92 20.14 5.78
Inventory Turnover (TTM) -- 2.36 3.35
Asset Turnover (TTM) 0.01 0.39 0.93

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -52.07 -1.05 10.98
Return on Assets - 5 Yr. Avg. -- -0.57 12.37
Return on Investment (TTM) -55.45 1.66 14.43
Return on Investment - 5 Yr. Avg. -- 2.23 16.18
Return on Equity (TTM) -55.50 2.58 16.13
Return on Equity - 5 Yr. Avg. -- 3.13 17.47
  1 Year 3 Year 5 Year
Sales % -88.43 -59.61 -23.58
EPS (TTM) % -34.58 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Xenon Pharmaceuticals Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 60.47%
# of Holders: 38
Total Shares Held: 10,883,815
3 Mo. Net Change: -547,105
# New Positions: 8
# Closed Positions: 5
# Increased Positions: 18
# Reduced Positions: 7
# Net Buyers: 11
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.